Answers are grounded in this paper and cite their sources.
A case report identifies human parvovirus B19 co-infection exacerbating renal injury in HFRS, suggesting routine screening importance.
Hemorrhagic fever with renal syndrome (HFRS), a significant rodent-borne disease in Eurasia, particularly in China, can lead to acute kidney injury, coagulation abnormalities, and even death. Co-infection with other pathogens typically exacerbates and complicates this disease. In this study, through metagenomic analysis, we identified the co-infection with human parvovirus B19 (PV B19) in a 41-year-old man with HFRS and no other underlying disease. In addition to typical HFRS symptoms, he exhibited a longer duration of renal injury than other patients with HFRS, along with a persistent decrease in erythrocytes and hemoglobin. The complete PV B19 genome was amplified and showed 86.6–99.7% nucleotide identity and 94.0–100.0% amino acid identity to known PV B19 strains. Phylogenetic analysis revealed that the newly identified PV B19 strain clustered with genotype 1a and had the closest relationship with strain HZ1/China-HZ from Zhejiang Province, China. This study emphasizes that routine screening for PV B19 co-infection in patients with HFRS is essential, particularly in cases with a prolonged course, and persistent decreases in erythrocytes and hemoglobin.
No takes yet. Share an insight, caveat, or question.
Che et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: